Healthcare, Industrials Jul 05, 2021 02:50 PM (GMT+8) · EqualOcean
Recently, "Zhishan medical" has completed a round of B + financing of over 100 million yuan. This round of financing is led by CPE Yuanfeng fund, followed by old shareholders Shanlan capital, Everbright capital and Yuansheng venture capital. The fund will be mainly used for multicenter clinical research, registration and commercial promotion of spheriatm intragastric weight loss balloon products, and part of it will be used for R & D and production of weight loss balloon products. Zhishan medical is a leading innovative technology enterprise focusing on weight loss and metabolism medical products in China. Its spheriatm intragastric balloon product is the first non-invasive and swallowable weight loss medical device in China.